New Study Shows Spironolactone Reduces Heart Failure Hospitalizations, But …HealthCanal.comBoston, MA – A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, …
Mayo Clinic-led Study: Two Drugs do not Improve Kidney Function in Acute … – HealthCanal.com
Mayo Clinic-led Study: Two Drugs do not Improve Kidney Function in Acute …HealthCanal.comPrevious smaller studies showed that low-dose dopamine or low-dose nesiritide could improve kidney function and reduce fluid overload that is often present in ho…
Queen Latifah's mother not fighting lung cancer – Newstrack India
IANS |
Queen Latifah’s mother not fighting lung cancer
Newstrack India Nov 19 (IANS) Singer-actress Queen Latifah dismissed reports suggesting her mother is battling lung cancer. A US tabloid recently reported that Latifah’s mother, Rita Owen, was struggling with the deadly disease, reports contactmusic.com. However … Latifah’s mother not fighting lung cancerIANS |
Queen Latifah's mother not fighting lung cancer – Yahoo India News
|
Queen Latifah’s mother not fighting lung cancer
Yahoo India News Nov 19 (IANS) Singer-actress Queen Latifah dismissed reports suggesting her mother is battling lung cancer. A US tabloid recently reported that Latifah’s mother, Rita Owen, was struggling with the deadly disease, reports contactmusic.com. However … |
Spironolactone Reduces Heart Failure Hospitalizations, but Not Mortality … – Science Daily (press release)
Medscape |
Spironolactone Reduces Heart Failure Hospitalizations, but Not Mortality …
Science Daily (press release) 18, 2013 — A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, to be presented at the American Heart Association (AHA) Scientific Sessions, November 18, 2013 … AHA: Decision on Spironolactone in HF a Toss-Up?MedPage Today Aldo-Antagonist Falls Short but Impresses in Preserved-EF Heart Failure: TOPCATMedscape |
New study shows spironolactone reduces heart failure hospitalizations, but not … – Eureka! Science News
New study shows spironolactone reduces heart failure hospitalizations, but not …Eureka! Science NewsA late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, to b…
New Nomenclature, Diagnostic Criteria: Antibody-Mediated Rejection in Heart … – Science Daily (press release)
|
New Nomenclature, Diagnostic Criteria: Antibody-Mediated Rejection in Heart …
Science Daily (press release) 18, 2013 — Antibody-mediated rejection of the transplanted heart is a recognized clinical complication and a major limitation to survival of patients who have undergone heart transplantation. Experts have now developed a new working formulation for … New ISHLT nomenclature and diagnostic criteria: Antibody-mediated rejection in …Medical Xpress |
'Stable but critical' Nelson Mandela responding to treatment – Times of India
AFP |
‘Stable but critical’ Nelson Mandela responding to treatment
Times of India Mandela’s former wife Winnie Madikizela-Mandela this week told a local newspaper that he remains “quite ill” and is unable to speak because of tubes being used to clear his lungs of liquid. He is using facial expressions to communicate, Madikizela … Mandela ‘stable but critical’MorungExpress Nelson Mandela very sensitive to germs, says ex-wife WinnieIndia Today Nelson Mandela remains stable but critical, informs South African governmentIBNLive Fars News Agency –Zee News all 268 news articles » |
Burkitt's Yields to Longer-Duration, Lower-Dose Chemo – Medscape
Medscape |
Burkitt’s Yields to Longer-Duration, Lower-Dose Chemo
Medscape For 19 adults with sporadic Burkitt’s lymphoma, a dose-adjusted version of the EPOCH-R (etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, and rituximab) regimen was associated with 95% progression-free survival and 100% overall … Low-intensity therapy very effective in Burkitt lymphomaOncology Nurse Advisor |
Combination Therapy For Severe Alcoholic Hepatitis Does Not Result in … – Toronto NewsFIX
Combination Therapy For Severe Alcoholic Hepatitis Does Not Result in …Toronto NewsFIXFour weeks of treatment with a combination of the drug pentoxifylline and the corticosteroid prednisolone did not improve 6-month survival compared with prednisolon…